###begin article-title 0
###xml 49 55 <span type="species:ncbi:9606">Humans</span>
TXNIP Regulates Peripheral Glucose Metabolism in Humans
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Type 2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and action. Impaired glucose uptake in skeletal muscle is believed to be one of the earliest features in the natural history of T2DM, although underlying mechanisms remain obscure.
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 112 151 112 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thioredoxin interacting protein (TXNIP)</italic>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 827 832 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 12 17 <span type="species:ncbi:9606">human</span>
We combined human insulin/glucose clamp physiological studies with genome-wide expression profiling to identify thioredoxin interacting protein (TXNIP) as a gene whose expression is powerfully suppressed by insulin yet stimulated by glucose. In healthy individuals, its expression was inversely correlated to total body measures of glucose uptake. Forced expression of TXNIP in cultured adipocytes significantly reduced glucose uptake, while silencing with RNA interference in adipocytes and in skeletal muscle enhanced glucose uptake, confirming that the gene product is also a regulator of glucose uptake. TXNIP expression is consistently elevated in the muscle of prediabetics and diabetics, although in a panel of 4,450 Scandinavian individuals, we found no evidence for association between common genetic variation in the TXNIP gene and T2DM.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 93 98 <span type="species:ncbi:9606">human</span>
TXNIP regulates both insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle. Combined with recent studies that have implicated TXNIP in pancreatic beta-cell glucose toxicity, our data suggest that TXNIP might play a key role in defective glucose homeostasis preceding overt T2DM.
###end p 6
###begin p 7
###xml 134 139 <span type="species:ncbi:9606">human</span>
Vamsi Mootha, Leif Groop, and colleagues report that TXNIP regulates insulin-dependent and -independent pathways of glucose uptake in human skeletal muscle and that its expression is elevated in individuals with prediabetes and type 2 diabetes.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
###xml 74 80 <span type="species:ncbi:9606">people</span>
###xml 188 194 <span type="species:ncbi:9606">people</span>
An epidemic of diabetes mellitus is threatening world health. 246 million people (6% of the world's population) already have diabetes and it is estimated that within 20 years, 380 million people will have this chronic disease, most of them in developing countries. Diabetes is characterized by high blood sugar (glucose) levels. It arises when the pancreas does not make enough insulin (type 1 diabetes) or when the body responds poorly to insulin (type 2 diabetes). Insulin, which is released in response to high blood glucose levels, instructs muscle, fat, and liver cells to take glucose (a product of food digestion) out of the bloodstream; cells use glucose as a fuel. Type 2 diabetes, which accounts for 90% of all cases of diabetes, is characterized by impaired glucose uptake by target tissues in response to insulin (this "insulin resistance" is one of the first signs of type 2 diabetes) and inappropriate glucose release from liver cells. Over time, the pancreas may also make less insulin. These changes result in poor glucose homeostasis (inadequate control of blood sugar levels), which can cause life-threatening complications such as kidney failure and heart attacks.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
If the world diabetes epidemic is to be halted, researchers need a better understanding of glucose homeostasis and need to identify which parts of this complex control system go awry in type 2 diabetes. This information might suggest ways to prevent type 2 diabetes developing in the first place and might reveal targets for drugs that could slow or reverse the disease process. In this study, the researchers have used multiple approaches to identify a new mediator of glucose homeostasis and to investigate whether this mediator is causally involved in the development of type 2 diabetes.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 298 338 298 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thioredoxin interacting protein (TXNIP),</italic>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 724 729 724 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 906 911 906 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1024 1029 1024 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1128 1133 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1218 1223 1218 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 47 53 <span type="species:ncbi:9606">people</span>
###xml 556 564 <span type="species:ncbi:9606">patients</span>
###xml 819 825 <span type="species:ncbi:9606">people</span>
###xml 977 983 <span type="species:ncbi:9606">people</span>
The researchers took small muscle samples from people who did not have diabetes before and after increasing their blood insulin levels and used a technique called "microarray expression profiling" to identify genes whose expression was induced or suppressed by insulin. One of the latter genes was thioredoxin interacting protein (TXNIP), a gene whose expression is strongly induced by glucose yet suppressed by insulin. They next used previously published microarray expression data to show that TXNIP expression was consistently higher in the muscles of patients with diabetes or prediabetes (a condition in which blood glucose levels are slightly raised) than in normal individuals. The researchers then examined whether TXNIP expression was correlated with glucose uptake, again using previously published data. In people with no diabetes and those with prediabetes, as glucose uptake rates increased, TXNIP expression decreased but this inverse correlation was missing in people with diabetes. Finally, by manipulating TXNIP expression levels in insulin-responsive cells grown in the laboratory, the researchers found that TXNIP overexpression reduced basal and insulin-stimulated glucose uptake but that reduced TXNIP expression had the opposite effect.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 708 713 708 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1048 1053 1048 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1278 1283 1278 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 90 96 <span type="species:ncbi:9606">people</span>
###xml 196 201 <span type="species:ncbi:9606">human</span>
These results provide strong evidence that TXNIP is a regulator of glucose homeostasis in people. Specifically, the researchers propose that TXNIP regulates glucose uptake in the periphery of the human body by acting as a glucose- and insulin-sensitive switch. They also suggest how it might be involved in the development of type 2 diabetes. Early in the disease process, a small insulin deficiency or slightly raised blood sugar levels would increase TXNIP expression in muscles and suppress glucose uptake by these cells. Initially, the pancreas would compensate for this by producing more insulin, but this compensation would eventually fail, allowing blood sugar levels to rise sufficiently to increase TXNIP expression in the pancreas. Previously published results suggest that this would induce the loss of insulin-producing cells in the pancreas, thus further reducing insulin production and glucose uptake in the periphery and, ultimately, resulting in type 2 diabetes. Although there are many unanswered questions about the exact role of TXNIP in glucose homeostasis, these results help to explain many of the changes in glucose control that occur early in the development of diabetes. Furthermore, they suggest that interventions designed to modulate the activity of TXNIP might break the vicious cycle that eventually leads to type 2 diabetes.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
The  encyclopedia has pages on diabetes
###end p 19
###begin p 20
###xml 25 33 <span type="species:ncbi:9606">patients</span>
The  has information for patients on diabetes
###end p 20
###begin p 21
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Information on diabetes is available for patients and professionals from the
###end p 21
###begin p 22
###xml 42 50 <span type="species:ncbi:9606">patients</span>
The  provides information on diabetes for patients
###end p 22
###begin p 23
 has information on diabetes and a
###end p 23
###begin title 24
Introduction
###end title 24
###begin p 25
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b001">1</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b002">2</xref>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b004">4</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b005">5</xref>
###xml 730 731 730 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b006">6</xref>
###xml 928 929 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b007">7</xref>
Type 2 diabetes mellitus (T2DM) is a growing worldwide epidemic that is characterized by defects in insulin secretion, failure to suppress hepatic glucose output, and impaired glucose uptake in target tissues, such as skeletal muscle and fat [1]. Impaired glucose uptake in muscle (both insulin-dependent and -independent) is believed to be one of the earliest features in the natural history of T2DM, and insulin resistance predicts future T2DM [2-4]. Although obesity is the most important risk factor for insulin resistance in the prediabetic state [5], other factors such as the toxic effects of elevated glucose (glucotoxicity) and lipids (lipotoxicity) also contribute to insulin resistance with progression of the disease [6]. The mechanisms by which glucose and lipids induce insulin resistance are not entirely clear but are thought to involve increased serine phosphorylation and deactivation of the insulin receptor [7].
###end p 25
###begin p 26
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
In the current study, we combined evidence from human physiology, genome-wide expression profiling, human genetics, and in vitro studies to study novel mechanisms of skeletal muscle insulin resistance and to identify mediators of glucose homeostasis that may be causally involved in the development of T2DM.
###end p 26
###begin title 27
Methods
###end title 27
###begin title 28
###xml 9 21 <span type="species:ncbi:9606">Participants</span>
Clinical Participants and Evaluation
###end title 28
###begin p 29
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b008">8</xref>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b009">9</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b010">10</xref>
###xml 900 908 900 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-st001">Table S1</xref>
###xml 86 98 <span type="species:ncbi:9606">Participants</span>
###xml 452 464 <span type="species:ncbi:9606">participants</span>
###xml 643 655 <span type="species:ncbi:9606">participants</span>
###xml 848 860 <span type="species:ncbi:9606">participants</span>
Results from three separate clinical studies (studies A, B, and C) are reported here. Participants in all three studies underwent an oral glucose (75 g) tolerance test, and glucose tolerance was diagnosed according to the World Health Organization criteria [8]. Studies A and B included six nondiabetic volunteers, while study C included 96 young (aged 25-32 y) nondiabetic twins. Details of study C were described previously [9,10]. None of the study participants were engaged in vigorous exercise on a routine basis, and they were directed to avoid extreme physical exercise and alcohol intake for at least 2 d before the studies. The study participants were asked to fast for 10-12 h before examination days. Oral and written approval was obtained from each individual in all of the clinical studies. Clinical and biochemical characteristics of participants in studies A, B, and C are provided in Table S1. All clinical studies were approved by the regional Ethics Committees and were conducted according to the principles of the Helsinki Declaration.
###end p 29
###begin title 30
Clamp Studies
###end title 30
###begin title 31
Studies A and C.
###end title 31
###begin p 32
###xml 40 49 40 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-sg001">Figure S1</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b010">10</xref>
###xml 274 275 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 408 409 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 415 416 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 547 548 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The clamp protocol for studies A and C (Figure S1) involved a 2-h hyperinsulinemic euglycemic clamp preceded by a 30-min intravenous glucose tolerance test (IVGTT) to determine first-phase insulin secretion as previously described [10]. A primed continuous infusion of a 3-[3H]-glucose tracer was supplied from the time point -160 min and throughout the clamp experiments. The basal glucose turnover rates (Ra and Rd) were determined during steady state conditions from -70 to -40 min. After the IVGTT a primed continuous insulin infusion (40 mU/m2/min) was initiated and continued for 2 h. The insulin-stimulated steady state period was defined as the last 30 min of the 2-h clamp period. A variable infusion of glucose (180 g/l) enriched with tritiated glucose (100 muCi/500 ml) maintained euglycemia during insulin infusion, with monitoring of plasma glucose concentration every 5-10 min during the basal and clamp periods using an automated glucose oxidation method (Glucose Analyzer 2, Beckman Instruments, ). Indirect calorimetry was performed during the basal and insulin-stimulated steady state periods using a computerized flow-through canopy gas analyzer system (Deltarac, Datex, ).
###end p 32
###begin title 33
Study B.
###end title 33
###begin p 34
###xml 32 41 32 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-sg001">Figure S1</xref>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The clamp protocol for study B (Figure S1) involved a 3-h hyperinsulinemic (infusion rate 40 mU/m2/min) euglycemic clamp in order to increase the effects of insulin on gene expression. A variable infusion of glucose (180 g/l) was used to maintain euglycemia during insulin infusion with monitoring of plasma glucose concentration every 5-10 min using an automated glucose oxidation method (Glucose Analyzer 2, Beckman Instruments). No IVGTT was performed prior to the insulin infusion. Furthermore, no glucose tracers or indirect calorimetry was performed.
###end p 34
###begin title 35
Skeletal Muscle Biopsies
###end title 35
###begin p 36
###xml 100 109 100 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-sg001">Figure S1</xref>
###xml 189 198 189 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-sg001">Figure S1</xref>
###xml 457 469 <span type="species:ncbi:9606">participants</span>
From -40 to -30 min (i.e., prior to the IVGTT), a basal muscle biopsy was taken in studies A and C (Figure S1). In study B, the basal muscle biopsy was obtained before insulin stimulation (Figure S1). The second (insulin-stimulated) muscle biopsy was taken at the time point +120 min in studies A and C, whereas in study B it was taken at the time point +180 min. The muscle biopsies were obtained from the vastus lateralis muscle under local anesthesia in participants participating in all three studies using a modified Bergstrom needle (including suction) before and after the hyperinsulinemic euglycemic clamps. Thus, both biopsies were determined during carefully standardized basal and insulin-stimulated euglycemic conditions. Biopsies were immediately frozen in liquid nitrogen and stored at -80 degreesC for later analysis.
###end p 36
###begin title 37
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Biochemical Calculations
###end title 37
###begin p 38
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b010">10</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b010">10</xref>
Plasma insulin concentrations were analyzed as previously described [10]. Insulin-stimulated glucose uptake was defined as the glucose infusion rate during steady state of the clamp. The glucose uptake and glucose oxidation were expressed per kilogram of lean body mass as determined by DEXA scan as previously described [10]. Nonoxidative glucose metabolism was calculated as glucose uptake minus glucose oxidation as determined by indirect calorimetry.
###end p 38
###begin title 39
RNA Isolation, Target Preparation, and Hybridization
###end title 39
###begin p 40
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b011">11</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b012">12</xref>
###xml 137 142 <span type="species:ncbi:9606">human</span>
RNA from skeletal muscle biopsies for studies A and B were extracted by the guadinium thiocyanate method [11]. For study A, targets from human skeletal muscle biopsies [12] were hybridized to the Affymetrix HG-U133A GeneChip (), whereas for study B, targets were hybridized to the Affymetrix Hu6800 GeneChip. For both studies, we considered scans only for which there were more than 10% present-calls and the GAPDH 3'/GAPDH 5' expression ratio was below 3.
###end p 40
###begin title 41
Real-Time PCR
###end title 41
###begin p 42
###xml 612 624 611 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP, G0S2,</italic>
###xml 629 633 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6</italic>
###xml 730 779 729 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Peptidylprolyl isomerase A (cyclophilin A) (PPIA)</italic>
###xml 983 996 982 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclophilin A</italic>
###xml 1295 1307 1294 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP, BCL6,</italic>
###xml 1312 1316 1311 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 1384 1392 1383 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-st001">Table S1</xref>
###xml 1361 1373 <span type="species:ncbi:9606">participants</span>
Extraction of total RNA from the muscle biopsies was performed with the TRI reagent (Sigma-Aldrich, ). In addition, RNA from cultured adipocytes was extracted using RNeasy Mini kit (Qiagen, ). cDNA was synthesized using Superscript II RNase H-Reverse Transcriptase (muscle biopsies; Life Technologies, ) or RevertAid H-M-MuLV Reverse Transcriptase (cultured adipocytes; Fermentas, ) and random hexamer primers (Life Technologies). Real-time PCR was performed in 10 mul using the ABI PRISM 7900 Sequence Detection system (Applied Biosystems, ) according to the manufacturer's instructions. Primers and probes for TXNIP, G0S2, and BCL6 mRNA were ordered as a ready-to-use mix of primers and FAM labeled probes (Applied Biosystems). Peptidylprolyl isomerase A (cyclophilin A) (PPIA) was used as an endogenous control to standardize the amount of cDNA added to the reactions using a ready to use mix of primers and a VIC-labeled probe (Applied Biosystems). Analysis of the expression of cyclophilin A on the microarrays from studies A and B suggested that its expression is not significantly altered by insulin (unpublished data). All samples were run in duplicate, and data were calculated using the standard curve method and expressed as a ratio to the cyclophilin A reference. Quantifications of TXNIP, BCL6, and G0S2 mRNA levels in study C were performed in 96 participants (study C, Table S1).
###end p 42
###begin title 43
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Adipocyte Cell Culture
###end title 43
###begin p 44
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b013">13</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 142 147 <span type="species:ncbi:9606">human</span>
Preadipocytes of human origin were obtained and passaged as previously described [13]. Fully differentiated cells were treated with media (2% human serum albumin added) supplemented with 1, 5, or 25 mM glucose with and without 1 nM insulin (a physiological concentration). After 4 h the cells were harvested for RNA extraction.
###end p 44
###begin title 45
###xml 25 30 <span type="species:ncbi:10090">Mouse</span>
###xml 54 59 <span type="species:ncbi:9606">Human</span>
Glucose Uptake Assays in Mouse Adipocytes and Primary Human Skeletal Muscle Cells
###end title 45
###begin title 46
Cell culture.
###end title 46
###begin p 47
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b014">14</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b015">15</xref>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 243 248 <span type="species:ncbi:10090">mouse</span>
###xml 571 576 <span type="species:ncbi:9606">human</span>
Primary human satellite cells were isolated from muscle biopsies obtained from healthy human volunteers by trypsin digestion and were grown to confluent myoblasts and differentiated into myotubes as previously described in detail [14]. 3T3-L1 mouse fibroblasts (ATCC) were cultured in DMEM and differentiated by standard means [15], via media supplemented with 5 mug/ml insulin, 0.25 muM dexamethasone, and 0.5 mM 3-isobutyl-1-methylxanthine (IBMX). Uptake assays were typically performed by day 10-12 postdifferentiation for adipocytes and day 5 postdifferentiation for human myotubes.
###end p 47
###begin title 48
RNA interference.
###end title 48
###begin p 49
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b016">16</xref>
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Txnip</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
Human skeletal muscle cells were seeded in six well plates at 2-3 x 104 cells/cm2. At 70%-80% confluence, myoblasts were induced to differentiate. On day 2 of differentiation, cells were transfected as described previously [16] with short interfering RNA (siRNA) directed against TXNIP (Dharmacon, ). Adipocytes were differentiated in 12-well plates, and cells were transfected with mouse Txnip-specific siRNA species (individual siRNA sequences, Ambion, ). We transfected 20 ng of siRNA or negative control scrambled siRNA (Ambion) in adipocytes on day 10 postdifferentiation using Express-si delivery reagent (Genospectra, ). Glucose uptake and Western analysis followed at 48-72 h posttransfection in the presence of high-glucose (25 mM) DMEM media.
###end p 49
###begin title 50
Viral transduction.
###end title 50
###begin p 51
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b017">17</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TXNIP was subcloned into the pCDH1-MCS1-EF1-Puro vector (System Biosciences, ). TXNIP or an empty vector was transfected into 293TN cells (ATCC) with Fugene 6 (Roche, ) to generate pseudoviral particles. GFP was cotransfected with a 1:100 ratio (pSIH1-H1-copGFP, System Biosciences), and multiplicity of infection (MOI) was determined by the number of GFP-positive cells detected by fluorescence microscopy at 96 h. Cells were cultured in low glucose (5.6 mM), transduced with an MOI of 1-2, and allowed to express viral proteins for 96 h before initiation of glucose uptake studies. Western blot analysis was performed on total cellular lysates separated on SDS-PAGE and transferred to PVDF membranes. Monoclonal antibodies were raised against full-length TXNIP as described previously [17], and antibodies to beta-actin were purchased from Sigma.
###end p 51
###begin title 52
Glucose uptake assays.
###end title 52
###begin p 53
###xml 217 218 211 212 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sc>
###xml 220 221 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 256 258 250 252 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> D</sc>
###xml 865 867 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b014">14</xref>
Virally infected or siRNA gene-silenced adipocytes were serum starved for 4 h, then incubated in Krebs-Ringer-Hepes with or without 100 nM recombinant insulin for 15 min at 37 degreesC. We added 0.5 mCi/ml of 2-deoxy-D-[3H]-glucose and 0.1 mM cold 2-deoxy- D-glucose, and the cells were incubated for five minutes at 25 degreesC. Uptake was terminated with ice-cold PBS containing 25 mM glucose, and cells were lysed in 0.5 ml of 1% Triton X-100/0.05% SDS at 60 degreesC for 10 min. Lysate radioactivity was measured by scintillation counting, and the data were expressed in pmol/mg lysate protein-min. Nonspecific glucose uptake was determined by the addition of cytochalasin B to 10 muM and was subtracted from measured values. Skeletal muscle glucose uptake assays were performed essentially as above, but with 6 nM insulin stimulation, as previously described [14].
###end p 53
###begin title 54
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
Resequencing of TXNIP
###end title 54
###begin p 55
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b009">9</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b018">18</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b019">19</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b020">20</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b021">21</xref>
###xml 934 939 934 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 941 949 941 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-st002">Table S2</xref>
We resequenced the TXNIP gene along with 2,200 bp upstream of the 5' end and 1,000 bp downstream of the 3' end in 48 individuals, 23 of whom showed expression of TXNIP in muscle in the highest quartile, while 25 had TXNIP expression in lowest quartile from our previous studies [9,18]. Genomic DNA was isolated from peripheral blood using standard procedures. We used specific primers (Applied Biosystems) to amplify the region by PCR. Sequencing was performed using Big Dye version 3.1 Cycle Sequencing kit (Applied Biosystems) according to the manufacturer's instructions, and separation was done on the ABI3730 DNA Analyzer. Each base was called using the PHRED software package [19,20], and quality scores were assigned. Sequence assembly and analysis were done using the Staden software package [21]. Three novel single nucleotide polymorphisms (SNPs), one novel insertion, and one novel deletion were identified by resequencing TXNIP (Table S2).
###end p 55
###begin title 56
Genetic Association Studies
###end title 56
###begin p 57
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 406 411 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 708 709 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 709 710 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b022">22</xref>
###xml 759 764 759 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1192 1194 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b023">23</xref>
###xml 1414 1415 1402 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1496 1498 1484 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b024">24</xref>
###xml 1882 1887 1870 1875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
We determined the pattern of genetic variation in individuals of European origin around the TXNIP locus (including 20 kb upstream and 10 kb downstream) using the HAPMAP database () and by genotyping an additional 33 SNPs (which also include three novel SNPs identified by resequencing) in the HAPMAP panel (90 normal individuals of European descent). In total, the pattern of linkage disequilibrium around TXNIP was ascertained from 15 polymorphic SNPs (32 SNPs were monomorphic, and six SNP assays failed). The gene lies in a region of high linkage disequilibrium; however, most SNPs identified were rare (<10% minor allele frequency). We selected nine tag SNPs to capture all genotypes and haplotypes with r2 over 0.8 [22]. To study the association between TXNIP variants and T2DM, nine tag SNPs and two missense SNPs were genotyped in approximately4,450 individuals. The sample population consisted of 333 Scandinavian parent-offspring trios, 1,189 discordant Scandinavian sib-pairs, and 1,084 case-control pairs (969 from Scandinavia and 125 from Canada). All case-control pairs were individually matched for sex, age, region of origin, and body mass index (BMI) as previously described [23]. Genotyping was performed by primer extension of multiplex products with detection by MALDI-TOF mass spectroscopy using a Sequenom platform. This study has >99% power to reject the null hypothesis of no association at p < 0.05 for a 10% allele assuming an OR of 1.3 and prevalence of diabetes of 8% [24]. Association of each tag SNP to type 2 diabetes was tested for each subsample, and the results were combined by Mantel-Haenszel meta-analysis. The two missense SNPs (rs6674773 and rs11537986) were monomorphic in the diabetes sample. For a subset of nondiabetic individuals in this study, fasting glucose and fasting insulin measurements were available. We tested for correlation of TXNIP SNP genotypes with four related quantitative phenotypes: fasting glucose, fasting insulin, homeostasis model assessment (HOMA-IR) as a measure of insulin resistance, and HOMA-beta (beta-cell function) as a measure of insulin secretion. For each SNP, we tested association to each quantitative trait under a general model, a dominant model, and a recessive model.
###end p 57
###begin title 58
Statistical Analysis
###end title 58
###begin title 59
Analysis of microarray data.
###end title 59
###begin p 60
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b025">25</xref>
All scans were subjected to global scaling to take into account intensity-related biases. For each scan, we scaled the expression intensity of all genes such that mean intensity of each scan equals mean intensity of one high-quality scan (scan GSM172123 AI for study A; scan GSM172162 for study B). We included only those probe sets for which percentage present calls were greater than 50% of all scans to remove probe sets that were not reliably detected [25]. For study A, we therefore considered a total of 5,059 out of 22,283 probe sets on HG-U133A chip. For study B, a total 1,177 out of 7,129 probe sets passed this filtering criterion.
###end p 60
###begin p 61
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b026">26</xref>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 354 355 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 369 373 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HES1</italic>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 462 466 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6</italic>
###xml 479 480 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 494 501 494 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC19A2</italic>
###xml 514 515 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 544 545 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 617 630 617 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G0S2, TXNIP,</italic>
###xml 635 640 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6)</italic>
###xml 715 722 715 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040158-t001">Table 1</xref>
We applied the significance analysis of microarrays [26] method for paired data by comparing pre- versus post-clamp log (base 2) transformed data (with >1.5-fold change, delta = 0.37, and median false discovery rate = 0%) to identify insulin-regulated genes from study A. Based on this analysis, we identified two insulin-induced genes, G0S2 (2.65-fold, p = 0.04), and HES1 (2.26-fold, p = 0.04), and three insulin-suppressed genes, TXNIP (2.39-fold, p = 0.04), BCL6 (2.13-fold, p = 0.04), and SLC19A2 (1.76-fold, p = 0.04) from study A, where p-values refer to Wilcoxon signed rank tests. Of these five genes, three (G0S2, TXNIP, and BCL6) proved to replicate in study B again using the Wilcoxon signed rank test (Table 1).
###end p 61
###begin title 62
Analysis of published microarray data.
###end title 62
###begin p 63
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b018">18</xref>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b027">27</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b029">29</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b027">27</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b029">29</xref>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
We analyzed the expression of individual genes using previously published microarray data [18,27-29]. Normalized data from these studies [27-29] were downloaded from the Web site for the Diabetes Genome Anatomy Project (DGAP, ). For interclass, unpaired comparisons, we used the Mann-Whitney U-test, a nonparametric statistic, to identify differences in expression of individual genes. Spearman rank correlations were used to relate expression levels with metabolic variables.
###end p 63
###begin title 64
###xml 12 24 12 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP, BCL6,</italic>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
Analysis of TXNIP, BCL6, and G0S2 mRNA levels by real-time PCR.
###end title 64
###begin p 65
###xml 124 136 124 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP, BCL6,</italic>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 172 180 172 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g001">Figure 1</xref>
The nonparametric statistic (Wilcoxon signed rank test) was used to identify significant differences between the groups for TXNIP, BCL6, and G0S2 mRNA levels from study C (Figure 1).
###end p 65
###begin title 66
Generalized estimating equation analysis.
###end title 66
###begin p 67
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b009">9</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b030">30</xref>
Study C included monozygotic and dizygotic twins. To relate expression data with insulin-stimulated glucose uptake, a GEE model was used to adjust for the interdependence between twins [9,30]. In this model the correlation is assumed to be different for monozygotic and dizygotic twins. The variables included in the model were selected using a backward selection regression with a significance level set to 0.05.
###end p 67
###begin title 68
Analysis for cellular glucose uptake studies.
###end title 68
###begin p 69
Differences between groups were determined using either the paired Student t-test (adipocytes) or two-way ANOVA (myocytes). Data are presented as mean +/- standard error.
###end p 69
###begin title 70
Results
###end title 70
###begin title 71
###xml 36 48 36 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP, G0S2,</italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6</italic>
###xml 61 66 <span type="species:ncbi:9606">Human</span>
Insulin Regulates the Expression of TXNIP, G0S2, and BCL6 in Human Skeletal Muscle
###end title 71
###begin p 72
###xml 372 381 372 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-sg001">Figure S1</xref>
###xml 383 391 383 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-st001">Table S1</xref>
###xml 397 404 397 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 579 592 579 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G0S2, TXNIP,</italic>
###xml 597 602 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6)</italic>
###xml 604 611 604 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040158-t001">Table 1</xref>
###xml 929 938 929 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-sg001">Figure S1</xref>
###xml 940 948 940 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-st001">Table S1</xref>
###xml 954 961 954 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 200 212 <span type="species:ncbi:9606">participants</span>
We began with a systematic screen to identify genes whose expression is responsive to the action of insulin in human skeletal muscle. Specifically, we obtained serial muscle biopsies from nondiabetic participants before and after a euglycemic hyperinsulinemic clamp using two different clinical protocols (study A and study B), each of which examined six individuals (see Figure S1; Table S1; and Methods). We then profiled gene expression in these biopsies using oligonucleotide microarrays. After stringent correction for multiple hypotheses testing, we identified three genes (G0S2, TXNIP, and BCL6) (Table 1) exhibiting differential expression before and after insulin treatment in both studies. All three genes were then independently validated by real-time PCR as being truly insulin responsive using archived RNA samples from a third clamp protocol (study C) that involved a panel of 96 young nondiabetic individuals (see Figure S1; Table S1; and Methods). Note that the expression of these three genes changed reproducibly across three different clamp protocols and quantitation platforms, suggesting that they represent robust changes in response to insulin.
###end p 72
###begin p 73
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6</italic>
###xml 121 129 121 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g001">Figure 1</xref>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 283 285 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b031">31</xref>
###xml 294 298 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6</italic>
###xml 403 405 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b032">32</xref>
###xml 464 466 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b033">33</xref>
###xml 702 704 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b034">34</xref>
###xml 746 751 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 811 819 803 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g001">Figure 1</xref>
###xml 860 865 852 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 959 961 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b035">35</xref>
###xml 977 979 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b036">36</xref>
###xml 1006 1008 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b037">37</xref>
###xml 1081 1083 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b038">38</xref>
###xml 380 385 <span type="species:ncbi:9606">human</span>
###xml 506 511 <span type="species:ncbi:4932">yeast</span>
###xml 1011 1014 <span type="species:ncbi:10116">rat</span>
Of these three genes, G0S2 was strongly induced by insulin, while TXNIP and BCL6 were consistently repressed by insulin (Figure 1). To our knowledge, none of these genes has previously been associated with insulin signaling. G0S2 was recently shown to be a target gene of PPARalpha [31], while BCL6 is a proto-oncogene that suppresses p53 and is implicated in the pathogenesis of human B cell lymphoma [32]. BCL6 has also been reported to interact with PPARdelta [33]. TXNIP was originally identified in a yeast two-hybrid screen for proteins that bind to thioredoxin, a protein that undergoes NADPH-dependent reduction and has roles in cellular signaling and reactive oxygen species (ROS) metabolism [34]. It is notable that whereas we identify TXNIP expression as being strongly repressed by insulin in vivo (Figure 1), many previous studies have identified TXNIP as being sharply induced by glucose in a variety of cell types, including pancreatic islets [35], fibroblasts [36], mesangial kidney cells [37], rat cardiomyocytes, and vascular endothelial and smooth muscle cells [38].
###end p 73
###begin title 74
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
TXNIP Expression Is Elevated in Skeletal Muscle of Individuals with Impaired Glucose Tolerance or T2DM
###end title 74
###begin p 75
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b018">18</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b027">27</xref>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 358 366 358 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g002">Figure 2</xref>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 457 465 457 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g002">Figure 2</xref>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 600 608 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g002">Figure 2</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b018">18</xref>
###xml 777 785 777 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g002">Figure 2</xref>
###xml 134 140 <span type="species:ncbi:9606">humans</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
Having identified three insulin-regulated genes, we sought to determine whether any of them exhibit altered expression in diabetes in humans. We analyzed two previously published microarray datasets of human diabetic and control muscle [18,27] and found that TXNIP expression was elevated in northern Europeans with impaired glucose tolerance (IGT) or T2DM (Figure 2A). While TXNIP expression was also elevated in the muscle of Mexican Americans with T2DM (Figure 2B), we found no evidence of an elevation of TXNIP expression in the muscle of healthy Mexican Americans with a family history of T2DM (Figure 2B). Although elevated circulating glucose levels could account for the observed differences in IGT and T2DM, it is notable that in our previous study [18], presented in Figure 2A, the muscle biopsies were obtained during conditions in which plasma glucose was clamped at the same level in all individuals.
###end p 75
###begin title 76
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
Suppression of TXNIP Expression by Insulin Requires Insulin Receptor Signaling
###end title 76
###begin p 77
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Txnip</italic>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b028">28</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b029">29</xref>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Txnip</italic>
###xml 357 358 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 531 536 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Txnip</italic>
###xml 576 577 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 761 763 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b029">29</xref>
###xml 839 844 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Txnip</italic>
###xml 890 891 887 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1010 1015 1007 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Txnip</italic>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
###xml 754 759 <span type="species:ncbi:10090">mouse</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
To determine whether the suppression of TXNIP by insulin in vivo is simply secondary to a decrease in circulating glucose, or due to a direct effect of insulin signaling, we examined Txnip gene expression using published microarray data from mice with disrupted insulin receptor signaling [28,29]. Txnip gene expression was more highly expressed (1.5-fold, p < 0.05) in the muscle of mice treated with streptozotocin, an agent that is selectively toxic to pancreatic beta-cells and results in insulin deficiency and hyperglycemia. Txnip expression levels reverted (0.53-fold, p < 0.05) to baseline in the muscle of these mice following treatment with insulin, which normalizes circulating glucose levels. However, in the muscle insulin receptor knockout mouse [29], treatment of streptozotocin-treated mice with insulin failed to suppress Txnip expression (1.33-fold increase with insulin, p = 0.08), despite the fact that glucose was well controlled in these mice. These data indicate that the suppression of Txnip by insulin is not simply secondary to a reduction in circulating glucose concentrations, but rather or in addition, requires intact insulin receptor signaling.
###end p 77
###begin title 78
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 69 74 <span type="species:ncbi:9606">Human</span>
TXNIP Expression Is Elevated by Glucose and Suppressed by Insulin in Human Muscle and Fat Cells in Culture
###end title 78
###begin p 79
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b039">39</xref>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 568 575 568 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 644 649 644 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 749 757 749 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g003">Figure 3</xref>
###xml 810 815 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 180 185 <span type="species:ncbi:9606">human</span>
###xml 541 546 <span type="species:ncbi:9606">human</span>
###xml 879 884 <span type="species:ncbi:9606">human</span>
To further confirm insulin's effect on TXNIP gene regulation, we analyzed TXNIP expression in cell culture. First, we analyzed microarray data from a published study that profiled human primary cultured myotubes following insulin treatment [39]. TXNIP expression was suppressed by more than 1.5-fold (p < 0.003) after four hours of insulin treatment, clearly demonstrating that the suppression of TXNIP can occur in the absence of any changes in circulating glucose concentrations. We also performed in vitro assays of TXNIP expression in a human adipocyte cell line (Methods) that is known to respond to insulin by stimulating glucose uptake. TXNIP expression increased following elevations in glucose concentration, and was suppressed by insulin (Figure 3). Together, these cell culture studies confirm that TXNIP expression is reciprocally regulated by insulin and glucose in human muscle and fat tissues.
###end p 79
###begin title 80
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
The Promoter of TXNIP Contains Conserved Regulatory Elements That May Account for Its Reciprocal Regulation by Insulin and Glucose
###end title 80
###begin p 81
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 182 191 182 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-sg002">Figure S2</xref>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b040">40</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b041">41</xref>
###xml 604 609 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b038">38</xref>
###xml 831 836 831 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
We hypothesized that the reciprocal regulation of TXNIP expression by insulin and glucose is likely mediated by highly conserved regulatory elements in the vicinity of its promoter (Figure S2). First, it contains tandem E-boxes that have been shown to account for the brisk response of TXNIP to glucose in the pancreas [40]. The promoter also contains an evolutionarily conserved binding site for the forkhead family of transcription factors. Because these forkhead family members are known to be excluded from the nucleus via Akt-mediated phosphorylation downstream of insulin signaling [41], and since TXNIP induction by glucose is blunted by the activation of the phosphatidylinositol-3-kinase/Akt pathway [38], this class of transcription factors represent excellent candidate mediators of the insulin-stimulated repression of TXNIP.
###end p 81
###begin title 82
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
TXNIP Expression Is Inversely Correlated with Insulin-Stimulated Glucose Uptake
###end title 82
###begin p 83
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 132 140 132 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g004">Figure 4</xref>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 234 237 234 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 252 255 252 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r =</italic>
###xml 263 266 263 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 306 309 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r =</italic>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 635 642 635 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 828 835 828 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 956 961 956 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1033 1037 1033 1037 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2max</sub>
###xml 1098 1099 1098 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1132 1133 1132 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1142 1147 1142 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1175 1176 1175 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1220 1224 1220 1224 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2max</sub>
###xml 1226 1227 1226 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1302 1309 1302 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040158-t002">Table 2</xref>
###xml 1359 1364 1359 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 124 130 <span type="species:ncbi:9606">humans</span>
###xml 286 294 <span type="species:ncbi:9606">patients</span>
###xml 1435 1441 <span type="species:ncbi:9606">humans</span>
We found that TXNIP expression is inversely correlated with the total body rate of insulin-stimulated glucose metabolism in humans (Figure 4). This relationship is robust in individuals with normal glucose tolerance (NGT) (r = -0.57, p = 0.02) or IGT (r = -0.86, p = 0.006), but not in patients with T2DM (r = -0.21, p = 0.41). To exclude the possibility that the relationship between TXNIP expression and glucose uptake could be a consequence, rather than a cause, of the metabolic derangements that precede T2DM we also related the expression of skeletal muscle TXNIP to glucose uptake in 96 healthy, young, nondiabetic individuals (Methods, study C). Since both dizygotic and monozygotic twins were included in the analysis, we used a generalized estimating equation model to correct for the relationship between twin pairs (Methods). In the analysis, we modeled insulin-stimulated glucose uptake as a function of age, sex, basal and insulin-stimulated TXNIP expression, zygosity, birth weight, percentage of body fat, BMI, and VO2max. Only four of these variables had explanatory power. Basal (p = 0.02) and insulin-stimulated (p < 0.01) TXNIP expression as well as BMI (p < 0.01) were inversely correlated, while VO2max (p < 0.01) was positively correlated with insulin-stimulated glucose uptake (Table 2). These data are consistent with the notion that TXNIP is an independent determinant of insulin-stimulated glucose uptake in humans.
###end p 83
###begin title 84
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
TXNIP Expression Governs Glucose Uptake in Insulin-Responsive Cells
###end title 84
###begin p 85
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 549 557 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g005">Figure 5</xref>
###xml 612 617 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 773 781 773 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g005">Figure 5</xref>
###xml 825 830 825 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1003 1011 1003 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g005">Figure 5</xref>
###xml 1073 1078 1073 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
###xml 852 857 <span type="species:ncbi:9606">human</span>
To directly test if TXNIP may regulate glucose uptake, we used genetic manipulations to alter the gene's expression in mouse and human cell lines. First we performed in vitro studies on an insulin-sensitive cell line, the adipocyte differentiated 3T3-L1. Incubation of the adipocytes with high glucose results in a potent induction of TXNIP protein (unpublished data). A 2-fold forced overexpression of TXNIP using lentiviral transduction resulted in both diminished basal and insulin-stimulated glucose uptake (59% and 28% reduction, respectively, Figure 5A). In agreement with this result, forced reduction of TXNIP expression by siRNA gene silencing achieved the opposite effect and enhanced both basal and insulin-stimulated glucose uptake (157% and 61%, respectively, Figure 5B). In addition, we examined the effects of TXNIP reduction in primary human skeletal muscle myocytes by siRNA gene silencing. Again, we observed a significant increase in both basal and insulin-stimulated glucose uptake (Figure 5C). Together, these in vitro studies indicate that changes in TXNIP expression can directly influence glucose uptake in insulin-responsive cells.
###end p 85
###begin title 86
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
Do Genetic Variants in the TXNIP Gene Increase Susceptibility to T2DM?
###end title 86
###begin p 87
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 415 422 415 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 424 432 424 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-st002">Table S2</xref>
###xml 582 590 582 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g006">Figure 6</xref>
###xml 650 655 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b042">42</xref>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b043">43</xref>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 894 901 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 903 910 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040158-t003">Table 3</xref>
###xml 1142 1150 1139 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040158-st003">Table S3</xref>
###xml 1197 1202 1194 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1311 1316 1308 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNXIP</italic>
###xml 111 117 <span type="species:ncbi:9606">humans</span>
###xml 262 268 <span type="species:ncbi:9606">humans</span>
While the above studies demonstrate that TXNIP is a physiologic regulator of peripheral glucose homeostasis in humans, we were next interested in determining whether genetic variation in this gene may be associated with measures of insulin resistance or T2DM in humans. We assessed the pattern of common genetic variation encompassing the TXNIP gene using data from the HapMap project and by resequencing the gene (Methods; Table S2). Then we performed a genetic association study of nine "tag" SNPs that capture the most common variation observed within the vicinity of this gene (Figure 6). This study was in part motivated by the observation that TXNIP is located on Chromosome 1q21.1, a region that has shown perhaps the most consistent linkage to T2DM [42,43]. In a clinical sample of 4,450 Scandinavian individuals, no significant association was detected between SNPs in TXNIP and T2DM (Methods; Table 3). Also, no significant association was observed between the genotypes and four quantitative phenotypes: fasting glucose, fasting insulin, HOMA-IR as a measure of insulin resistance, and HOMA-beta as a measure of insulin secretion (Table S3). Although we did not detect polymorphisms in TXNIP that are associated with T2DM, it is still formally possible that inherited variation in other genes in the TNXIP pathway may predispose to the risk of developing T2DM.
###end p 87
###begin title 88
Discussion
###end title 88
###begin p 89
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b044">44</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b045">45</xref>
###xml 392 394 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b035">35</xref>
###xml 424 429 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 656 661 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 750 755 747 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 793 798 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 197 203 <span type="species:ncbi:9606">humans</span>
###xml 226 232 <span type="species:ncbi:10090">murine</span>
###xml 846 852 <span type="species:ncbi:9606">humans</span>
We have combined human physiology, genome-wide expression profiling, genetic association testing, and cellular studies to spotlight TXNIP as a physiologic regulator of peripheral glucose uptake in humans. Our results build on murine studies that have established a role for this protein in the liver in the regulation of fasting:feeding transitions [44,45] and in beta-cell glucose toxicity [35]. While genetic variation in TXNIP does not predispose one's inherited risk for developing T2DM, TXNIP nonetheless appears to play a physiologic role in glucose homeostasis in muscle and in fat. Key novel results from the current study include the finding that TXNIP gene expression is reciprocally regulated by insulin and by glucose, that elevations in TXNIP can inhibit glucose uptake, and that TXNIP expression levels are consistently elevated in humans with T2DM and prediabetes.
###end p 89
###begin p 90
###xml 110 118 110 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g007">Figure 7</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b046">46</xref>
###xml 358 363 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b004">4</xref>
Our study shows that TXNIP is part of a negative feedback mechanism that regulates glucose uptake into cells (Figure 7A). Such a mechanism may serve to prevent excess glucose uptake or metabolism [46]. At present, it is not clear whether TXNIP influences the metabolic fate of glucose-future studies will be required to address this important issue. Because TXNIP expression is suppressed by insulin signaling, it appears that TXNIP influences both insulin-dependent and insulin-independent arms of glucose uptake into cells. Of note, epidemiological studies have suggested roles for both insulin-dependent and insulin-independent pathways in the development of T2DM [4].
###end p 90
###begin p 91
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b018">18</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b027">27</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b047">47</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b048">48</xref>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b049">49</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b038">38</xref>
###xml 706 711 706 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b050">50</xref>
Recent genomic studies have pointed to mitochondrial dysfunction and to ROS as possible culprits in the etiology of insulin resistance [18,27,47,48]. At present, we do not know how mitochondrial dysfunction and ROS are related to each other in the pathogenesis of insulin resistance. The current study, in combination with other recent studies, suggests that TXNIP may lie upstream of both of these processes. First, TXNIP expression is induced by glucocorticoids [49] and by glucose, and TXNIP elevations can stimulate ROS production [38]. Hence TXNIP represents a candidate intermediate linking diabetogenic stimuli to ROS production. Second, we have observed an inverse correlation in the expression of TXNIP and mitochondrial oxidative phosphorylation (unpublished data), and previous studies have shown that TXNIP can serve as a transcriptional repressor [50]. Taken together, these data raise the hypothesis that TXNIP may lie upstream of the elevations in ROS and mitochondrial dysfunction that accompany insulin resistance.
###end p 91
###begin p 92
###xml 99 101 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b040">40</xref>
###xml 195 203 192 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g007">Figure 7</xref>
###xml 247 248 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b001">1</xref>
###xml 249 251 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b051">51</xref>
###xml 321 323 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b052">52</xref>
###xml 324 326 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b053">53</xref>
###xml 373 375 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b054">54</xref>
###xml 533 535 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b046">46</xref>
###xml 536 538 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b047">47</xref>
###xml 557 559 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b040">40</xref>
###xml 575 580 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 730 735 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 903 908 891 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 1130 1138 1115 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040158-g007">Figure 7</xref>
###xml 1176 1181 1161 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 798 804 <span type="species:ncbi:9606">humans</span>
Importantly, our findings, in combination with recent studies focused on the pancreatic beta-cell [40], provide molecular insights into the pathogenesis of impaired insulin secretion and action (Figure 7B) that characterize the prediabetic state [1,51]. Hyperglycemia has long been known to exacerbate beta-cell failure [52,53] and impaired skeletal muscle glucose uptake [54] via a process often termed glucose toxicity. At present the molecular basis for glucose toxicity is not known, although ROS represent a candidate mediator [46,47]. A recent study [40] reported that TXNIP is glucose inducible in pancreatic beta-cells and may mediate beta-cell death through apoptosis. Our present study has led to the novel finding that TXNIP also plays a role in controlling peripheral glucose uptake in humans and may be an important target mediating effects of insulin. Together, these studies suggest that TXNIP may be involved in glucose toxicity both in beta-cells and in the periphery, helping to reconcile the dynamic relationship between insulin deficiency and impaired glucose uptake that is observed in the prediabetic state (Figure 7B). Interventions aimed at modulating TXNIP activity may therefore help curtail this vicious cycle that eventually leads to overt T2DM.
###end p 92
###begin title 93
Supporting Information
###end title 93
###begin title 94
Design of the Hyperinsulinemic, Euglycemic Clamp Protocols for Studies A, B, and C
###end title 94
###begin p 95
(352 KB PDF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin title 97
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 149 154 <span type="species:ncbi:9606">Human</span>
###xml 156 161 <span type="species:ncbi:10090">Mouse</span>
###xml 163 166 <span type="species:ncbi:10116">Rat</span>
###xml 172 175 <span type="species:ncbi:9615">Dog</span>
The Promoter of TXNIP Contains a Conserved Binding Site for the Tandem E-Boxes and for the Forkhead Family of Transcription Factors in Four Species (Human, Mouse, Rat, and Dog)
###end title 97
###begin p 98
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b056">56</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b035">35</xref>
Positions are relative to translation start site of TXNIP gene. See [56] for tandem E-boxes and [35] for forkhead family of transcription factors.
###end p 98
###begin p 99
(298 KB PDF)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin title 101
###xml 44 56 <span type="species:ncbi:9606">Participants</span>
Clinical and Biochemical Characteristics of Participants
###end title 101
###begin p 102
(58 KB DOC)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin title 104
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
TXNIP Resequencing in 48 Individuals
###end title 104
###begin p 105
(35 KB DOC)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin title 107
Genotype-Phenotype Correlations of TXNIP Tag SNPs with Fasting Glucose, Fasting Insulin, Insulin Resistance (Measured by HOMA-IR) and Insulin Secretion (Measured by HOMA-beta Cell Function) in Nondiabetic Individuals
###end title 107
###begin p 108
(157 KB DOC)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin title 110
Accession Numbers
###end title 110
###begin p 111
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6</italic>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HES1</italic>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC19A2</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARA</italic>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARD</italic>
The GenBank () accession numbers for the genes are TXNIP (10628), G0S2 (50486), BCL6 (604), HES1 (3280), SLC19A2 (10560), PPIA (5478), PPARA (5465), and PPARD (5467). The microarray data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) database (); series accession number is GSE7146.
###end p 111
###begin p 112
We are grateful to Evan Rosen, Todd Golub, and Eric Lander for valuable comments on this manuscript and to Leslie Gaffney for assistance in preparing the illustrations. We thank Andrew Norris and Ronald C. Kahn of the Diabetes Genome Anatomy Project for access to published microarray data.
###end p 112
###begin title 113
Abbreviations
###end title 113
###begin p 114
body mass index
###end p 114
###begin p 115
homeostasis model assessment
###end p 115
###begin p 116
impaired glucose tolerance
###end p 116
###begin p 117
intravenous glucose tolerance test
###end p 117
###begin p 118
normal glucose tolerance
###end p 118
###begin p 119
reactive oxygen species
###end p 119
###begin p 120
single nucleotide polymorphism
###end p 120
###begin p 121
type 2 diabetes mellitus
###end p 121
###begin title 122
References
###end title 122
###begin article-title 123
Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes
###end article-title 123
###begin article-title 124
###xml 27 34 <span type="species:ncbi:9606">persons</span>
Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus
###end article-title 124
###begin article-title 125
Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes
###end article-title 125
###begin article-title 126
Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study
###end article-title 126
###begin article-title 127
Metabolic consequences of a family history of NIDDM (the Botnia study): Evidence for sex-specific parental effects
###end article-title 127
###begin article-title 128
Muscle triglycerides and mitochondrial function: Possible mechanisms for the development of type 2 diabetes
###end article-title 128
###begin article-title 129
Cellular mechanisms of insulin resistance
###end article-title 129
###begin article-title 130
Impaired glucose tolerance in a middle-aged male urban population: A new approach for identifying high-risk cases
###end article-title 130
###begin article-title 131
Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins
###end article-title 131
###begin article-title 132
Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins
###end article-title 132
###begin article-title 133
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
###end article-title 133
###begin article-title 134
Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
###end article-title 134
###begin article-title 135
###xml 22 27 <span type="species:ncbi:9606">human</span>
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation
###end article-title 135
###begin article-title 136
###xml 27 32 <span type="species:ncbi:9606">human</span>
Insulin action in cultured human skeletal muscle cells during differentiation: Assessment of cell surface GLUT4 and GLUT1 content
###end article-title 136
###begin article-title 137
Acquisition of increased hormone sensitivity during in vitro adipocyte development
###end article-title 137
###begin article-title 138
###xml 97 102 <span type="species:ncbi:9606">human</span>
RNA interference-mediated reduction in GLUT1 inhibits serum-induced glucose transport in primary human skeletal muscle cells
###end article-title 138
###begin article-title 139
Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity
###end article-title 139
###begin article-title 140
###xml 100 105 <span type="species:ncbi:9606">human</span>
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
###end article-title 140
###begin article-title 141
Base-calling of automated sequencer traces using phred. II. Error probabilities
###end article-title 141
###begin article-title 142
Base-calling of automated sequencer traces using phred. I. Accuracy assessment
###end article-title 142
###begin article-title 143
The Staden sequence analysis package
###end article-title 143
###begin article-title 144
Efficiency and power in genetic association studies
###end article-title 144
###begin article-title 145
###xml 29 35 <span type="species:ncbi:9606">people</span>
Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes
###end article-title 145
###begin article-title 146
Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits
###end article-title 146
###begin article-title 147
Effects of filtering by Present call on analysis of microarray experiments
###end article-title 147
###begin article-title 148
Significance analysis of microarrays applied to the ionizing radiation response
###end article-title 148
###begin article-title 149
###xml 58 64 <span type="species:ncbi:9606">humans</span>
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1
###end article-title 149
###begin article-title 150
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice
###end article-title 150
###begin article-title 151
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Distinct pathways of insulin-regulated versus diabetes-regulated gene expression: An in vivo analysis in MIRKO mice
###end article-title 151
###begin article-title 152
Longitudinal data analysis for discrete and continuous outcomes
###end article-title 152
###begin article-title 153
The G0/G1 switch gene 2 is a novel PPAR target gene
###end article-title 153
###begin article-title 154
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
###end article-title 154
###begin article-title 155
Transcriptional repression of atherogenic inflammation: Modulation by PPARdelta
###end article-title 155
###begin article-title 156
Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression
###end article-title 156
###begin article-title 157
###xml 46 51 <span type="species:ncbi:9606">human</span>
Oligonucleotide microarray analysis of intact human pancreatic islets: Identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway
###end article-title 157
###begin article-title 158
###xml 99 102 <span type="species:ncbi:10116">Rat</span>
Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts
###end article-title 158
###begin article-title 159
Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells
###end article-title 159
###begin article-title 160
Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein
###end article-title 160
###begin article-title 161
###xml 42 47 <span type="species:ncbi:9606">human</span>
Expression profiling of insulin action in human myotubes: Induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes
###end article-title 161
###begin article-title 162
Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis
###end article-title 162
###begin article-title 163
Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization
###end article-title 163
###begin article-title 164
A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians
###end article-title 164
###begin article-title 165
Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24
###end article-title 165
###begin article-title 166
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic Txnip-/- mice
###end article-title 166
###begin article-title 167
Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition
###end article-title 167
###begin article-title 168
Biochemistry and molecular cell biology of diabetic complications
###end article-title 168
###begin article-title 169
Reactive oxygen species have a causal role in multiple forms of insulin resistance
###end article-title 169
###begin article-title 170
Mitochondrial dysfunction in the elderly: Possible role in insulin resistance
###end article-title 170
###begin article-title 171
Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis
###end article-title 171
###begin article-title 172
VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression
###end article-title 172
###begin article-title 173
Pathogenesis of type 2 diabetes mellitus
###end article-title 173
###begin article-title 174
Life and death of the pancreatic beta cells
###end article-title 174
###begin article-title 175
Minireview: Secondary beta-cell failure in type 2 diabetes-A convergence of glucotoxicity and lipotoxicity
###end article-title 175
###begin article-title 176
The effect of hyperglycaemia on glucose disposal and insulin signal transduction in skeletal muscle
###end article-title 176
###begin article-title 177
Haploview: Analysis and visualization of LD and haplotype maps
###end article-title 177
###begin article-title 178
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues
###end article-title 178
###begin title 179
Figures and Tables
###end title 179
###begin title 180
###xml 22 34 22 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP, BCL6,</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 58 63 <span type="species:ncbi:9606">Human</span>
Effects of Insulin on TXNIP, BCL6, and G0S2 Expression in Human Muscle In Vivo
###end title 180
###begin p 181
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 147 148 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 165 168 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;14</sup>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6</italic>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 199 201 199 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 236 239 236 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
mRNA levels were measured in skeletal muscle biopsies of healthy individuals before and after the hyperinsulinemic euglycemic clamp for (A) TXNIP (n = 96, p < 1 x 10-14), (B) BCL6 (n = 90, p < 1 x 10-5), and (C) G0S2 (n = 95, p < 1 x 10-16). Levels were measured using real-time PCR and normalized to cyclophilin A mRNA. Inset shows the distribution of expression changes over individuals. p-Values refer to the Wilcoxon signed rank statistic.
###end p 181
###begin title 182
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
TXNIP Expression in Individuals with Diabetes or at Risk for Developing Diabetes
###end title 182
###begin p 183
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b018">18</xref>
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
(A) TXNIP expression levels from individuals with NGT, IGT, or T2DM, using data from our previously published microarray study [18]. * p < 0.02; ** p < 0.01, Mann-Whitney U-test.
###end p 183
###begin p 184
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b027">27</xref>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
(B) TXNIP expression levels from NGT individuals with family history of T2DM (FH+) or without (FH-), as well as individuals with T2DM, using data from a previously published microarray study [27]. * p < 0.03, Mann-Whitney U-test.
###end p 184
###begin title 185
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 70 75 <span type="species:ncbi:9606">Human</span>
Effects of Glucose and Insulin on the Expression of TXNIP in Cultured Human Adipocytes
###end title 185
###begin p 186
###xml 220 221 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 243 244 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human adipocytes were cultured in the presence (black bars) or absence (white bars) of 1 nM insulin at varying levels of glucose. Data are presented as mean +/- standard deviation, normalized to the untreated control. * p < 0.05, Mann-Whitney U-test.
###end p 186
###begin title 187
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
Insulin-Mediated Glucose Uptake Versus TXNIP Expression
###end title 187
###begin p 188
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b018">18</xref>
This relationship is shown for individuals with NGT, IGT, and T2DM. Linear regression parameters are indicated for each of the groups. Data are from our previously published microarray study [18].
###end p 188
###begin title 189
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
Genetic Manipulation of TXNIP Expression Affects Both Basal and Insulin-Stimulated Glucose Uptake in Cultured Adipocytes and in Primary Skeletal Muscle Myocytes
###end title 189
###begin p 190
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 258 263 <span type="species:ncbi:9606">human</span>
(A) Differentiated 3T3-L1 adipocytes cultured in 5.6 mM glucose were transduced with human TXNIP or empty virus particles and allowed to express the genes for 96 h. Cell lysates were immunoblotted using antibodies against TXNIP or actin. The exogenous viral human TXNIP protein is present as the more slowly migrating of the two bands. Glucose uptake with and without insulin was measured as described in Methods. Each data point represents an n = 4. * p < 0.02; ** p < 0.005.
###end p 190
###begin p 191
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 239 240 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(B) Adipocytes cultured in 25 mM glucose were transfected with siRNA against TXNIP or with negative control siRNA and assayed 48 h posttransfection. Immunoblotting and glucose uptake are as above. n = 4 for each data point. * p < 0.02; ** p < 0.001.
###end p 191
###begin p 192
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 315 316 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 4 9 <span type="species:ncbi:9606">Human</span>
(C) Human skeletal muscle myoblasts obtained from biopsy were differentiated into myotubes in culture and transfected with siRNA against TXNIP or with negative control siRNA. Glucose uptake was measured at 72 h post-transfection with n = 4 for each data point. Each experiment was performed at least three times. * p < 0.01
###end p 192
###begin title 193
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
Pattern of Genetic Variation at the TXNIP Locus
###end title 193
###begin p 194
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b055">55</xref>
Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D' values were calculated with 95% confidence intervals. D' plot for each square depicts the magnitude of linkage disequilibrium for a pair of markers, red indicates high D' with high logarithm of odds (LOD) score, while white indicates low D' with low LOD score, and blue indicates high D' with low LOD score.
###end p 194
###begin title 195
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
Model of TXNIP Regulation and Action and Its Potential Role in the Pathogenesis of T2DM
###end title 195
###begin p 196
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
(A) Previous studies have shown that glucose induces the expression of TXNIP in a variety of cells and tissues. In this study we show that insulin suppresses the expression of TXNIP. Moreover, we have found that forced expression of TXNIP results in reduced glucose uptake, while inhibition of TXNIP enhances glucose uptake. These results suggest that TXNIP serves as a glucose- and insulin-sensitive homeostatic switch that regulates glucose uptake in the periphery.
###end p 196
###begin p 197
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 153 158 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 425 430 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 471 473 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040158-b040">40</xref>
(B) Role of TXNIP in glucose toxicity in the beta-cell and in impaired glucose uptake in the periphery. Insulin deficiency or hyperglycemia can increase TXNIP levels in muscle, resulting in impaired peripheral glucose uptake. The pancreatic beta-cell is initially able to compensate by secreting more insulin, but eventually the beta-cell compensation fails. The resulting hyperglycemia may then elevate pancreatic beta-cell TXNIP expression, which can induce apoptosis [40]. The loss of beta-cells, in turn, results in decreased insulin production that further exacerbates peripheral IGT. The vicious cycle would eventually spiral to T2DM.
###end p 197
###begin p 198
###xml 47 52 <span type="species:ncbi:9606">Human</span>
Expression of Three Insulin-Regulated Genes in Human Skeletal Muscle
###end p 198
###begin p 199
###xml 57 63 <span type="species:ncbi:9606">Humans</span>
Factors Influencing Insulin-Stimulated Glucose Uptake in Humans
###end p 199
###begin p 200
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
Association of TXNIP Tag SNPs with T2DM
###end p 200
###begin p 201
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
###xml 167 180 167 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLoS Medicine</italic>
Competing Interests: HT is employed at Novo Nordisk A/S, Denmark and owns a minor amount of employers stock in this Company. LCG is a member of the editorial board of PLoS Medicine.
###end p 201
###begin p 202
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP,</italic>
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 307 319 307 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP, G0S2,</italic>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6.</italic>
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Txnip</italic>
###xml 795 800 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 935 940 935 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TXNIP</italic>
###xml 236 241 <span type="species:ncbi:9606">human</span>
###xml 748 753 <span type="species:ncbi:9606">human</span>
###xml 818 823 <span type="species:ncbi:9606">human</span>
Author contributions. HP analysed the microarray data, performed the GEE analysis, carried out the resequencing of TXNIP, and drafted the manuscript. EC, LEJ, and MR studied the effects of glucose and insulin on TXNIP expression in the human adipocyte cell line and carried out the real-time PCR studies of TXNIP, G0S2, and BCL6. WAC, PCS, MJM, and RTL performed the glucose uptake studies in 3T3-L1 cells following genetic manipulation of Txnip expression. HS, PP, CBJ, and AV were responsible for the clinical and metabolic studies including the hyperinsulinemic euglycemic clamp studies. RS and DA were responsible for the genetic association studies. CL performed the microarray experiments. AK, MB, and JRZ performed glucose uptake studies in human skeletal muscle cells following siRNA of TXNIP. HT provided the human adipocyte cell line and was involved in planning the experiments studying the effect of glucose and insulin on TXNIP expression in these cells. LCG and VKM conceived the project, designed the study, and jointly supervised all phases of the study as well as the drafting of the manuscript.
###end p 202
###begin p 203
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: This work was supported by grants from the Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at the Center for Medical Innovations at the Karolinska Institute (HP), Deutsche Akademie der Naturforscher, Leopoldina (PCS), the Pahlsson Foundation (MR), National Heart, Lung, Blood Institute (RTL), the EXGENESIS grant (005272) from the European Union (JRZ, AV, and LCG), the Swedish Research Council (MR and LCG), the Burroughs Wellcome Fund (VKM), and the American Diabetes Association/Smith Family Foundation (VKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 203

